Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study.

Front Pharmacol · 2022 · PMC9424766 · PMID 36052140

Europe PMC DOI

hedged sentence

0.0630

closest p · 1.3× alpha

0.0630

boldest claim

The sentences

a trend towards significancep = 0.063so close (0.05 < p ≤ 0.1)

p = 0.031) and a trend towards significance for the FVC (T0: 73 ± 21.14; T1: 80 ± 17.83 p = 0.063).

also in 2,760 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.